This document is an excerpt from the EUR-Lex website
Document 32019R0227
Commission Delegated Regulation (EU) 2019/227 of 28 November 2018 amending Delegated Regulation (EU) No 1062/2014 as regards certain active substances/product-type combinations for which the competent authority of the United Kingdom has been designated as the evaluating competent authority (Text with EEA relevance.)
Commission Delegated Regulation (EU) 2019/227 of 28 November 2018 amending Delegated Regulation (EU) No 1062/2014 as regards certain active substances/product-type combinations for which the competent authority of the United Kingdom has been designated as the evaluating competent authority (Text with EEA relevance.)
Commission Delegated Regulation (EU) 2019/227 of 28 November 2018 amending Delegated Regulation (EU) No 1062/2014 as regards certain active substances/product-type combinations for which the competent authority of the United Kingdom has been designated as the evaluating competent authority (Text with EEA relevance.)
C/2018/7778
OJ L 37, 8.2.2019, p. 1–21
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
In force
|
8.2.2019 |
EN |
Official Journal of the European Union |
L 37/1 |
COMMISSION DELEGATED REGULATION (EU) 2019/227
of 28 November 2018
amending Delegated Regulation (EU) No 1062/2014 as regards certain active substances/product-type combinations for which the competent authority of the United Kingdom has been designated as the evaluating competent authority
(Text with EEA relevance)
THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products (1) and in particular the first subparagraph of Article 89(1) thereof,
Whereas:
|
(1) |
Commission Delegated Regulation (EU) No 1062/2014 (2) sets out in its Annex II a list of active substance/product-type combinations included in the programme of review of existing active substances contained in biocidal products (‘review programme’). |
|
(2) |
The competent authority of the United Kingdom of Great Britain and Northern Ireland (‘the United Kingdom’) is the evaluating competent authority for several active substance/product-type combinations listed in Annex II to Delegated Regulation (EU) No 1062/2014. |
|
(3) |
The United Kingdom submitted on 29 March 2017 the notification of its intention to withdraw from the Union pursuant to Article 50 of the Treaty on European Union. As a result, the United Kingdom will withdraw from the Union on 30 March 2019 and the Union legislation will no longer apply to and in the United Kingdom. A withdrawal agreement is currently being negotiated between the European Union and the United Kingdom, which includes a ‘transition period’. According to draft provisions of the Withdrawal Agreement as agreed between the EU and the United Kingdom at negotiator's level, during the transition period, a competent authority of the United Kingdom can not act as evaluating competent authority for any active substance/product-type combination included in the review programme. Moreover, there is no certainty whether the Withdrawal Agreement, once finalised, will be signed and ratified by both parties, and this before the 30 March 2019. |
|
(4) |
Therefore, as regards the active substances/product-type combinations included in the review programme for which the competent authority of the United Kingdom has been designated as the evaluating competent authority, it is necessary to designate a new evaluating competent authority from among the competent authorities of the remaining 27 Member States of the European Union, EEA countries, or Switzerland, with effect from 30 March 2019. |
|
(5) |
Notwithstanding the stage of evaluation of the application, the Member States whose competent authorities are designated to replace that of the United Kingdom should be allowed to request fees for the services provided, in accordance with Article 80 of Regulation (EU) No 528/2012. |
|
(6) |
Taking into account that the review programme has to be finalised by the target date indicated in Article 89(1) of Regulation (EU) No 528/2012, appropriate time limits should be established for finalising the evaluations of the reallocated applications for active substance/product-type combinations. |
|
(7) |
Delegated Regulation (EU) No 1062/2014 should therefore be amended accordingly, |
HAS ADOPTED THIS REGULATION:
Article 1
Delegated Regulation (EU) No 1062/2014 is amended as follows:
|
(1) |
the following Article is inserted: ‘Article 6a Applications for which the competent authority of the United Kingdom was the evaluating competent authority before 30 March 2019 1. This Article is applicable to applications for which the competent authority of the United Kingdom was the evaluating competent authority before 30 March 2019 for the entries 79, 85, 113, 171, 187, 188, 321, 345, 346, 458, 531, 554, 571, 599, 609, 1045, 1046 and 1047 of Annex II. 2. The evaluating competent authority of a Member State having replaced the competent authority of the United Kingdom in relation to an application that has been submitted before 30 March 2019, shall inform the participant of the fees payable under Article 80(2) of Regulation (EU) No 528/2012 at the latest by 30 April 2019, and shall reject the application if the participant fails to pay the fees within a period of time fixed by the evaluating competent authority. It shall inform the participant and the Agency accordingly. 3. By derogation from the time limits laid down in Article 6(3), the assessment report and the conclusions shall be sent by the evaluating competent authority within either of the following time limits, whichever is the later:
|
|
(2) |
the table set out in Annex II is replaced by the table set out in the Annex to this Regulation. |
Article 2
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
It shall apply from 30 March 2019.
This Regulation shall be binding in its entirety and directly applicable in all Member States.
Done at Brussels, 28 November 2018.
For the Commission
The President
Jean-Claude JUNCKER
(1) OJ L 167, 27.6.2012, p. 1.
(2) Commission Delegated Regulation (EU) No 1062/2014 of 4 August 2014 on the work programme for the systematic examination of all existing active substances contained in biocidal products referred to in Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 294, 10.10.2014, p. 1).
ANNEX
The table set out in Annex II to Delegated Regulation (EU) No 1062/2014 is replaced by the following table:
|
‘Entry number |
Substance name |
Rapporteur Member State |
EC number |
CAS number |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
17 |
18 |
19 |
21 |
22 |
|
1 |
Formaldehyde |
DE |
200-001-8 |
50-00-0 |
|
x |
x |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x |
|
9 |
Bronopol |
ES |
200-143-0 |
52-51-7 |
|
x |
|
|
|
x |
|
|
x |
|
x |
x |
|
|
|
|
|
x |
|
36 |
Ethanol |
EL |
200-578-6 |
64-17-5 |
x |
x |
|
x |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
37 |
Formic acid |
BE |
200-579-1 |
64-18-6 |
|
x |
x |
x |
x |
x |
|
|
|
|
x |
x |
|
|
|
|
|
|
|
1025 |
Performic acid generated from formic acid and hydrogen peroxide |
BE |
|
|
|
x |
x |
x |
x |
x |
|
|
|
|
x |
x |
|
|
|
|
|
|
|
43 |
Salicylic acid |
NL |
200-712-3 |
69-72-7 |
|
x |
x |
x |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
52 |
Ethylene oxide |
NO |
200-849-9 |
75-21-8 |
|
x |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
69 |
Glycolic acid |
NL |
201-180-5 |
79-14-1 |
|
x |
x |
x |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1026 |
Peracetic acid generated from tetraacetylethylenediamine (TAED) and hydrogen peroxide |
AT |
|
|
|
x |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1027 |
Peracetic acid generated from 1,3-diacetyloxypropan-2-yl acetate and hydrogen peroxide |
AT |
|
|
|
x |
|
x |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1028 |
Peracetic acid generated from tetraacetylethylenediamine (TAED) and sodium perborate monohydrate |
AT |
|
|
|
|
x |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1029 |
Peracetic acid generated by perhydrolysis of N-acetylcaprolactam by hydrogen peroxide in alkaline conditions |
AT |
|
|
|
x |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
71 |
L-(+)-lactic acid |
DE |
201-196-2 |
79-33-4 |
|
|
|
|
|
x |
|
|
|
|
|
|
|
|
|
|
|
|
|
79 |
(2R,6aS,12aS)-1,2,6,6a,12,12a-Hexahydro-2-isopropenyl-8,9-dimethoxychromeno[3,4-b]furo[2,3-h]chromen-6-one (Rotenone) |
PL |
201-501-9 |
83-79-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
x |
|
|
|
|
|
85 |
Symclosene |
DE |
201-782-8 |
87-90-1 |
|
x |
x |
x |
x |
|
|
|
|
|
x |
x |
|
|
|
|
|
|
|
92 |
Biphenyl-2-ol |
ES |
201-993-5 |
90-43-7 |
|
|
|
|
|
|
x |
|
x |
x |
|
|
|
|
|
|
|
|
|
113 |
3-Phenyl-propen-2-al (Cinnamaldehyde) |
PL |
203-213-9 |
104-55-2 |
|
x |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
117 |
Geraniol |
FR |
203-377-1 |
106-24-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x |
x |
|
|
|
122 |
Glyoxal |
FR |
203-474-9 |
107-22-2 |
|
x |
x |
x |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
133 |
Hexa-2,4-dienoic acid (Sorbic acid) |
DE |
203-768-7 |
110-44-1 |
|
|
|
|
|
x |
|
|
|
|
|
|
|
|
|
|
|
|
|
154 |
Clorophene |
NO |
204-385-8 |
120-32-1 |
|
x |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
171 |
2-Phenoxyethanol |
IT |
204-589-7 |
122-99-6 |
x |
x |
|
x |
|
x |
|
|
|
|
|
|
x |
|
|
|
|
|
|
1072 |
Carbon dioxide |
FR |
204-696-9 |
124-38-9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x |
|
|
|
179 |
Carbon dioxide generated from propane, butane or a mixture of both by combustion |
FR |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x |
|
|
|
180 |
Sodium dimethylarsinate (Sodium Cacodylate) |
PT |
204-708-2 |
124-65-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x |
|
|
|
|
185 |
Tosylchloramide sodium (Chloramin T) |
ES |
204-854-7 |
127-65-1 |
|
x |
x |
x |
x |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
187 |
Potassium dimethyldithiocarbamate |
SE |
204-875-1 |
128-03-0 |
|
|
|
|
|
|
|
|
x |
|
x |
x |
|
|
|
|
|
|
|
188 |
Sodium dimethyldithiocarbamate |
SE |
204-876-7 |
128-04-1 |
|
|
|
|
|
|
|
|
x |
|
x |
x |
|
|
|
|
|
|
|
195 |
Sodium 2-biphenylate |
ES |
205-055-6 |
132-27-4 |
|
|
|
x |
|
x |
x |
|
x |
x |
|
|
x |
|
|
|
|
|
|
206 |
Thiram |
BE |
205-286-2 |
137-26-8 |
|
|
|
|
|
|
|
|
x |
|
|
|
|
|
|
|
|
|
|
210 |
Metam-sodium |
BE |
205-293-0 |
137-42-8 |
|
|
|
|
|
|
|
|
x |
|
x |
|
|
|
|
|
|
|
|
227 |
2-Thiazol-4-yl-1H-benzoimidazole (Thiabendazole) |
ES |
205-725-8 |
148-79-8 |
|
|
|
|
|
|
x |
|
x |
x |
|
|
|
|
|
|
|
|
|
235 |
Diuron |
DK |
206-354-4 |
330-54-1 |
|
|
|
|
|
|
x |
|
|
x |
|
|
|
|
|
|
|
|
|
239 |
Cyanamide |
DE |
206-992-3 |
420-04-2 |
|
|
x |
|
|
|
|
|
|
|
|
|
|
|
x |
|
|
|
|
253 |
Tetrahydro-3,5-dimethyl-1,3,5-thiadiazine-2-thione (Dazomet) |
BE |
208-576-7 |
533-74-4 |
|
|
|
|
|
x |
|
|
|
|
|
x |
|
|
|
|
|
|
|
283 |
Terbutryn |
SK |
212-950-5 |
886-50-0 |
|
|
|
|
|
|
x |
|
x |
x |
|
|
|
|
|
|
|
|
|
292 |
(1,3,4,5,6,7-Hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl (1R-trans)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate (d-Tetramethrin) |
DE |
214-619-0 |
1166-46-7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x |
|
|
|
|
321 |
Monolinuron |
HU |
217-129-5 |
1746-81-2 |
|
x |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
330 |
N-(3-Aminopropyl)-N-dodecylpropane-1,3-diamine (Diamine) |
PT |
219-145-8 |
2372-82-9 |
|
x |
x |
x |
|
x |
|
x |
|
|
x |
x |
x |
|
|
|
|
|
|
336 |
2,2′-Dithiobis[N-methylbenzamide] (DTBMA) |
PL |
219-768-5 |
2527-58-4 |
|
|
|
|
|
x |
|
|
|
|
|
|
|
|
|
|
|
|
|
339 |
1,2-Benzisothiazol-3(2H)-one (BIT) |
ES |
220-120-9 |
2634-33-5 |
|
x |
|
|
|
x |
|
|
x |
|
x |
x |
x |
|
|
|
|
|
|
341 |
2-Methyl-2H-isothiazol-3-one (MIT) |
SI |
220-239-6 |
2682-20-4 |
|
|
|
|
|
x |
|
|
|
|
|
|
|
|
|
|
|
|
|
346 |
Sodium dichloroisocyanurate dihydrate |
DE |
220-767-7 |
51580-86-0 |
|
x |
x |
x |
x |
|
|
|
|
|
x |
x |
|
|
|
|
|
|
|
345 |
Troclosene sodium |
DE |
220-767-7 |
2893-78-9 |
|
x |
x |
x |
x |
|
|
|
|
|
x |
x |
|
|
|
|
|
|
|
348 |
Mecetronium ethylsulfate (MES) |
PL |
221-106-5 |
3006-10-8 |
x |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
359 |
Formaldehyde released from (Ethylenedioxy)dimethanol (Reaction products of ethylene glycol with paraformaldehyde (EGForm)) |
PL |
222-720-6 |
3586-55-8 |
|
x |
|
|
|
x |
|
|
|
|
x |
x |
x |
|
|
|
|
|
|
365 |
Pyridine-2-thiol 1-oxide, sodium salt (Sodium pyrithione) |
SE |
223-296-5 |
3811-73-2 |
|
x |
|
|
|
x |
x |
|
x |
x |
|
|
x |
|
|
|
|
|
|
368 |
Methenamine 3-chloroallylochloride (CTAC) |
PL |
223-805-0 |
4080-31-3 |
|
|
|
|
|
x |
|
|
|
|
|
x |
x |
|
|
|
|
|
|
377 |
2,2′,2″-(Hexahydro-1,3,5-triazine-1,3,5-triyl)triethanol (HHT) |
PL |
225-208-0 |
4719-04-4 |
|
|
|
|
|
x |
|
|
|
|
x |
x |
x |
|
|
|
|
|
|
382 |
Tetrahydro-1,3,4,6-tetrakis(hydroxymethyl)imidazo[4,5-d]imidazole-2,5(1H,3H)-dione (TMAD) |
ES |
226-408-0 |
5395-50-6 |
|
x |
|
|
|
x |
|
|
|
|
x |
x |
x |
|
|
|
|
|
|
392 |
Methylene dithiocyanate |
FR |
228-652-3 |
6317-18-6 |
|
|
|
|
|
|
|
|
|
|
|
x |
|
|
|
|
|
|
|
393 |
1,3-Bis(hydroxymethyl)-5,5-dimethylimidazolidine-2,4-dione (DMDMH) |
PL |
229-222-8 |
6440-58-0 |
|
|
|
|
|
x |
|
|
|
|
|
|
x |
|
|
|
|
|
|
397 |
Didecyldimethylammonium chloride (DDAC) |
IT |
230-525-2 |
7173-51-5 |
x |
x |
x |
x |
|
x |
|
|
|
x |
x |
x |
|
|
|
|
|
|
|
401 |
Silver |
SE |
231-131-3 |
7440-22-4 |
|
x |
|
x |
x |
|
|
|
|
|
x |
|
|
|
|
|
|
|
|
1023 |
Silver, as a nanomaterial |
SE |
231-131-3 |
7440-22-4 |
|
x |
|
x |
|
|
|
|
x |
|
|
|
|
|
|
|
|
|
|
405 |
Sulfur dioxide generated from sulfur by combustion |
DE |
|
|
|
|
|
x |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
424 |
Active bromine generated from sodium bromide and sodium hypochlorite |
NL |
|
|
|
x |
|
|
|
|
|
|
|
|
x |
x |
|
|
|
|
|
|
|
1030 |
Active bromine generated from sodium bromide and calcium hypochlorite |
NL |
|
|
|
x |
|
|
|
|
|
|
|
|
x |
x |
|
|
|
|
|
|
|
1031 |
Active bromine generated from sodium bromide and chlorine |
NL |
|
|
|
x |
|
|
|
|
|
|
|
|
x |
x |
|
|
|
|
|
|
|
1032 |
Active bromine generated from sodium bromide by electrolysis |
NL |
|
|
|
x |
|
|
|
|
|
|
|
|
x |
x |
|
|
|
|
|
|
|
1033 |
Active bromine generated from hypobromous acid and urea and bromourea |
NL |
|
|
|
|
|
|
|
|
|
|
|
|
x |
x |
|
|
|
|
|
|
|
1034 |
Active bromine generated from sodium hypobromite and N-bromosulfamate and sulfamic acid |
NL |
|
|
|
|
|
|
|
|
|
|
|
|
x |
|
|
|
|
|
|
|
|
1035 |
Active bromine generated from ozone and bromide of natural water and sodium bromide |
NL |
|
|
|
x |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
434 |
Tetramethrin |
DE |
231-711-6 |
7696-12-0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x |
|
|
|
|
439 |
Hydrogen peroxide |
FI |
231-765-0 |
7722-84-1 |
|
|
|
|
|
|
|
|
|
|
x |
x |
|
|
|
|
|
|
|
1036 |
Hydrogen peroxide released from sodium percarbonate |
FI |
|
|
|
x |
x |
|
x |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
444 |
7a-Ethyldihydro-1H,3H,5H-oxazolo[3,4-c]oxazole (EDHO) |
PL |
231-810-4 |
7747-35-5 |
|
|
|
|
|
x |
|
|
|
|
|
|
x |
|
|
|
|
|
|
450 |
Silver nitrate |
SE |
231-853-9 |
7761-88-8 |
x |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
453 |
Disodium peroxodisulfate |
PT |
231-892-1 |
7775-27-1 |
|
|
|
x |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
432 |
Active chlorine released from sodium hypochlorite |
IT |
|
|
|
|
|
|
|
|
|
|
|
|
x |
x |
|
|
|
|
|
|
|
455 |
Active chlorine released from calcium hypochlorite |
IT |
|
|
|
|
|
|
|
|
|
|
|
|
x |
|
|
|
|
|
|
|
|
457 |
Active chlorine released from chlorine |
IT |
|
|
|
|
|
|
|
|
|
|
|
|
x |
|
|
|
|
|
|
|
|
458 |
Monochloramine generated from ammonium sulfate and a chlorine source |
FR |
|
|
|
|
|
|
|
|
|
|
|
|
x |
x |
|
|
|
|
|
|
|
1016 |
Silver chloride |
SE |
232-033-3 |
7783-90-6 |
x |
x |
|
|
|
x |
x |
|
x |
|
|
|
|
|
|
|
|
|
|
473 |
Pyrethrins and Pyrethroids |
ES |
232-319-8 |
8003-34-7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x |
x |
|
|
|
491 |
Chlorine dioxide |
DE |
233-162-8 |
10049-04-4 |
|
x |
x |
x |
x |
|
|
|
|
|
x |
x |
|
|
|
|
|
|
|
1037 |
Chlorine dioxide generated from sodium chlorite by electrolysis |
PT |
|
|
|
x |
x |
x |
x |
|
|
|
|
|
x |
x |
|
|
|
|
|
|
|
1038 |
Chlorine dioxide generated from sodium chlorite by acidification |
PT |
|
|
|
x |
x |
x |
x |
|
|
|
|
|
x |
x |
|
|
|
|
|
|
|
1039 |
Chlorine dioxide generated from sodium chlorite by oxidation |
PT |
|
|
|
x |
x |
x |
x |
|
|
|
|
|
x |
x |
|
|
|
|
|
|
|
1040 |
Chlorine dioxide generated from sodium chlorate and hydrogen peroxide in the presence of a strong acid |
PT |
|
|
|
x |
|
|
x |
|
|
|
|
|
x |
x |
|
|
|
|
|
|
|
1041 |
Chlorine dioxide generated from sodium chloride by electrolysis |
DE |
|
|
|
x |
x |
x |
x |
|
|
|
|
|
x |
x |
|
|
|
|
|
|
|
1042 |
Chlorine dioxide generated from sodium chlorite and sodium bisulfate and hydrochloric acid |
DE |
|
|
|
|
|
x |
x |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1043 |
Chlorine dioxide generated from sodium chlorite and sodium bisulfate |
DE |
|
|
|
x |
x |
x |
x |
|
|
|
|
|
x |
x |
|
|
|
|
|
|
|
1044 |
Chlorine dioxide generated from sodium chlorite and sodium persulfate |
DE |
|
|
|
x |
x |
x |
x |
|
|
|
|
|
x |
x |
|
|
|
|
|
|
|
494 |
2,2-Dibromo-2-cyanoacetamide (DBNPA) |
DK |
233-539-7 |
10222-01-2 |
|
x |
|
x |
|
x |
|
|
|
|
x |
x |
x |
|
|
|
|
|
|
501 |
Carbendazim |
DE |
234-232-0 |
10605-21-7 |
|
|
|
|
|
|
x |
|
x |
x |
|
|
|
|
|
|
|
|
|
1022 |
Dialuminium chloride pentahydroxide |
NL |
234-933-1 |
12042-91-0 |
|
x |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
515 |
Bromide activated chloramine (BAC) generated from precursors ammonium bromide and sodium hypochlorite |
SE |
|
|
|
|
|
|
|
|
|
|
|
|
x |
x |
|
|
|
|
|
|
|
522 |
Pyrithione zinc |
SE |
236-671-3 |
13463-41-7 |
|
x |
|
|
|
x |
x |
|
x |
x |
|
|
|
|
|
|
x |
|
|
524 |
Dodecylguanidine monohydrochloride |
ES |
237-030-0 |
13590-97-1 |
|
|
|
|
|
x |
|
|
|
|
x |
|
|
|
|
|
|
|
|
529 |
Active bromine generated from bromine chloride |
NL |
|
|
|
|
|
|
|
|
|
|
|
|
x |
|
|
|
|
|
|
|
|
531 |
(Benzyloxy)methanol |
AT |
238-588-8 |
14548-60-8 |
|
|
|
|
|
x |
|
|
|
|
|
|
x |
|
|
|
|
|
|
550 |
D-Gluconic acid, compound with N,N′-bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediamidine (2:1) (CHDG) |
PT |
242-354-0 |
18472-51-0 |
x |
x |
x |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
554 |
p-[(Diiodomethyl)sulphonyl]toluene |
CH |
243-468-3 |
20018-09-1 |
|
|
|
|
|
x |
x |
|
x |
x |
|
|
|
|
|
|
|
|
|
559 |
(Benzothiazol-2-ylthio)methyl thiocyanate (TCMTB) |
NO |
244-445-0 |
21564-17-0 |
|
|
|
|
|
|
|
|
x |
|
|
x |
|
|
|
|
|
|
|
562 |
2-Methyl-4-oxo-3-(prop-2-ynyl)cyclopent-2-en-1-yl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate (Prallethrin) |
EL |
245-387-9 |
23031-36-9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x |
|
|
|
|
563 |
Potassium (E,E)-hexa-2,4-dienoate (Potassium Sorbate) |
DE |
246-376-1 |
24634-61-5 |
|
|
|
|
|
x |
|
|
|
|
|
|
|
|
|
|
|
|
|
566 |
Reaction products of paraformaldehyde and 2-hydroxypropylamine (ratio 1:1) (HPT) |
AT |
|
|
|
x |
|
|
|
x |
|
|
|
|
x |
|
x |
|
|
|
|
|
|
571 |
2-Octyl-2H-isothiazol-3-one (OIT) |
FR |
247-761-7 |
26530-20-1 |
|
|
|
|
|
x |
x |
|
x |
x |
x |
|
x |
|
|
|
|
|
|
577 |
Dimethyloctadecyl[3-(trimethoxysilyl)propyl]ammonium chloride |
ES |
248-595-8 |
27668-52-6 |
|
x |
|
|
|
|
x |
|
x |
|
|
|
|
|
|
|
|
|
|
588 |
Bromochloro-5,5-dimethylimidazolidine-2,4-dione (BCDMH) |
NL |
251-171-5 |
32718-18-6 |
|
x |
|
|
|
|
|
|
|
|
x |
x |
|
|
|
|
|
|
|
590 |
3-(4-Isopropylphenyl)-1,1-dimethylurea (Isoproturon) |
DE |
251-835-4 |
34123-59-6 |
|
|
|
|
|
|
x |
|
|
x |
|
|
|
|
|
|
|
|
|
597 |
1-[2-(Allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole (Imazalil) |
DE |
252-615-0 |
35554-44-0 |
|
|
x |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
599 |
S-[(6-Chloro-2-oxooxazolo[4,5-b]pyridin-3(2H)-yl)methyl] O,O-dimethyl thiophosphate (Azamethiphos) |
IT |
252-626-0 |
35575-96-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x |
|
|
|
|
608 |
Dimethyltetradecyl[3-(trimethoxysilyl)propyl]ammonium chloride |
PL |
255-451-8 |
41591-87-1 |
|
|
|
|
|
|
|
|
x |
|
|
|
|
|
|
|
|
|
|
1045 |
Eucalyptus citriodora oil, hydrated, cyclized |
CZ |
|
1245629-80-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x |
|
|
|
1046 |
Cymbopogon winterianus oil, fractionated, hydrated, cyclized |
CZ |
Not available |
Not available |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x |
|
|
|
1047 |
Eucalyptus citriodora oil and citronellal, hydrated, cyclized |
CZ |
Not available |
Not available |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x |
|
|
|
609 |
2-Hydroxy-α,α,4-trimethylcyclohexanemethanol |
CZ |
255-953-7 |
42822-86-6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x |
|
|
|
619 |
3-Iodo-2-propynylbutylcarbamate (IPBC) |
DK |
259-627-5 |
55406-53-6 |
|
|
|
|
|
|
x |
|
x |
x |
|
|
|
|
|
|
|
|
|
620 |
Tetrakis(hydroxymethyl)phosphonium sulphate(2:1) (THPS) |
MT |
259-709-0 |
55566-30-8 |
|
|
|
|
|
x |
|
|
|
|
x |
x |
|
|
|
|
|
|
|
648 |
4,5-Dichloro-2-octylisothiazol-3(2H)-one (4,5-Dichloro-2-octyl-2H-isothiazol-3-one (DCOIT)) |
NO |
264-843-8 |
64359-81-5 |
|
|
|
|
|
|
x |
|
x |
x |
x |
|
|
|
|
|
|
|
|
656 |
Reaction products of paraformaldehyde and 2-hydroxypropylamine (ratio 3:2) (MBO) |
AT |
|
|
|
x |
|
|
|
x |
|
|
|
|
x |
x |
x |
|
|
|
|
|
|
667 |
Alkyl (C12-18) dimethylbenzyl ammonium chloride (ADBAC (C12-18)) |
IT |
269-919-4 |
68391-01-5 |
x |
x |
x |
x |
|
|
|
|
|
x |
x |
x |
|
|
|
|
|
x |
|
671 |
Alkyl (C12-16) dimethylbenzyl ammonium chloride (ADBAC/BKC (C12-C16)) |
IT |
270-325-2 |
68424-85-1 |
x |
x |
x |
x |
|
|
|
|
|
x |
x |
x |
|
|
|
|
|
x |
|
673 |
Didecyldimethylammonium chloride (DDAC (C8-10)) |
IT |
270-331-5 |
68424-95-3 |
x |
x |
x |
x |
|
x |
|
|
|
x |
x |
x |
|
|
|
|
|
|
|
690 |
Quaternary ammonium compounds, benzyl-C12-18-alkyldimethyl, salts with 1,2-benzisothiazol-3(2H)-one 1,1-dioxide (1:1) (ADBAS) |
MT |
273-545-7 |
68989-01-5 |
|
x |
|
x |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
691 |
Sodium N-(hydroxymethyl)glycinate |
AT |
274-357-8 |
70161-44-3 |
|
|
|
|
|
x |
|
|
|
|
|
|
|
|
|
|
|
|
|
692 |
Amines, C10-16-alkyldimethyl, N-oxides |
PT |
274-687-2 |
70592-80-2 |
|
|
|
x |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
693 |
Pentapotassium bis(peroxymonosulfate)bis(sulfate) (KPMS) |
SI |
274-778-7 |
70693-62-8 |
|
x |
x |
x |
x |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
939 |
Active chlorine generated from sodium chloride by electrolysis |
SK |
|
|
|
x |
x |
x |
x |
|
|
|
|
|
x |
x |
|
|
|
|
|
|
|
1048 |
Active chlorine released from hypochlorous acid |
SK |
|
|
|
x |
x |
x |
x |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1049 |
Active chlorine generated from sodium chloride and pentapotassium bis(peroxymonosulfate)bis(sulfate) |
SI |
|
|
|
x |
x |
x |
x |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1050 |
Active chlorine generated from seawater (sodium chloride) by electrolysis |
FR |
|
|
|
|
|
|
|
|
|
|
|
|
x |
|
|
|
|
|
|
|
|
1051 |
Active chlorine generated from magnesium chloride hexahydrate and potassium chloride by electrolysis |
FR |
|
|
|
x |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1052 |
Active chlorine generated from magnesium chloride hexahydrate by electrolysis |
FR |
|
|
|
x |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1053 |
Active chlorine generated from potassium chloride by electrolysis |
DK |
|
|
|
x |
|
x |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1054 |
Active chlorine generated from sodium N-chlorosulfamate |
SI |
|
|
|
|
|
x |
|
|
|
|
|
|
x |
x |
|
|
|
|
|
|
|
1055 |
Active chlorine generated from sodium chloride and pentapotassium bis(peroxymonosulfate)bis(sulfate) and sulfamic acid |
SI |
|
|
|
x |
x |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1056 |
Active chlorine generated from hydrochloric acid by electrolysis |
SI |
|
|
|
x |
|
x |
x |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
701 |
Dihydrogen bis[monoperoxyphthalato(2-)-O1,OO1]magnesate(2-) (MMPP) |
PL |
279-013-0 |
84665-66-7 |
|
x |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1024 |
Margosa extract from cold-pressed oil of the kernels of Azadirachta Indica extracted with super-critical carbon dioxide |
DE |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x |
|
|
|
|
724 |
Alkyl (C12-C14) dimethylbenzylammonium chloride (ADBAC (C12-C14)) |
IT |
287-089-1 |
85409-22-9 |
x |
x |
x |
x |
|
|
|
|
|
x |
x |
x |
|
|
|
|
|
x |
|
725 |
Alkyl (C12-C14) dimethyl(ethylbenzyl)ammonium chloride (ADEBAC (C12-C14)) |
IT |
287-090-7 |
85409-23-0 |
x |
x |
x |
x |
|
|
|
|
|
x |
x |
x |
|
|
|
|
|
x |
|
731 |
Chrysanthemum cinerariaefolium, ext. |
ES |
289-699-3 |
89997-63-7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x |
|
|
|
|
1057 |
Chrysanthemum cinerariaefolium extract from open and mature flowers of Tanacetum cinerariifolium obtained with hydrocarbon solvent |
ES |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x |
x |
|
|
|
1058 |
Chrysanthemum cinerariaefolium extract from open and mature flowers of Tanacetum cinerariifolium obtained with supercritical carbon dioxide |
ES |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x |
x |
|
|
|
744 |
Lavender, Lavandula hybrida, ext./Lavandin oil |
PT |
294-470-6 |
91722-69-9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x |
|
|
|
779 |
Reaction products of: glutamic acid and N-(C12-C14-alkyl)propylenediamine (Glucoprotamin) |
DE |
403-950-8 |
164907-72-6 |
|
x |
|
x |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
785 |
6-(Phthalimido)peroxyhexanoic acid (PAP) |
IT |
410-850-8 |
128275-31-0 |
x |
x |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
791 |
2-Butyl-benzo[d]isothiazol-3-one (BBIT) |
CZ |
420-590-7 |
4299-07-4 |
|
|
|
|
|
x |
x |
|
x |
x |
|
|
x |
|
|
|
|
|
|
792 |
Chlorine dioxide generated from tetrachlorodecaoxide complex (TCDO) by acidification |
DE |
|
|
|
x |
|
x |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
811 |
Silver sodium hydrogen zirconium phosphate |
SE |
422-570-3 |
265647-11-8 |
x |
x |
|
x |
|
|
x |
|
x |
|
|
|
|
|
|
|
|
|
|
794 |
sec-Butyl 2-(2-hydroxyethyl)piperidine-1-carboxylate (Icaridine) |
DK |
423-210-8 |
119515-38-7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x |
|
|
|
797 |
cis-1-(3-Chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride (cis CTAC) |
PL |
426-020-3 |
51229-78-8 |
|
|
|
|
|
x |
|
|
|
|
|
|
x |
|
|
|
|
|
|
813 |
Peroxyoctanoic acid |
FR |
|
33734-57-5 |
|
x |
x |
x |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1014 |
Silver zeolite |
SE |
Not available |
Not available |
|
x |
|
x |
x |
|
x |
|
x |
|
|
|
|
|
|
|
|
|
|
152 |
Reaction products of 5,5-dimethylhydantoin, 5-ethyl-5-methylhydantoin with bromine and chlorine (DCDMH) |
NL |
Not available |
Not available |
|
|
|
|
|
|
|
|
|
|
x |
|
|
|
|
|
|
|
|
459 |
Reaction mass of titanium dioxide and silver chloride |
SE |
Not available |
Not available |
x |
x |
|
|
|
x |
x |
|
x |
x |
x |
|
|
|
|
|
|
|
|
777 |
Reaction products of 5,5-dimethylhydantoin, 5-ethyl-5-methylhydantoin with chlorine (DCEMH) |
NL |
Not available |
Not available |
|
|
|
|
|
|
|
|
|
|
x |
|
|
|
|
|
|
|
|
810 |
Silver phosphate glass |
SE |
Not available |
308069-39-8 |
|
x |
|
|
|
|
x |
|
x |
|
|
|
|
|
|
|
|
|
|
824 |
Silver zinc zeolite |
SE |
Not available |
130328-20-0 |
|
x |
|
x |
|
|
x |
|
x |
|
|
|
|
|
|
|
|
|
|
1013 |
Silver copper zeolite |
SE |
Not available |
130328-19-7 |
|
x |
|
x |
|
|
x |
|
x |
|
|
|
|
|
|
|
|
|
|
1017 |
Silver adsorbed on silicon dioxide (as a nanomaterial in the form of a stable aggregate with primary particles in the nanoscale) |
SE |
Not available |
Not available |
|
|
|
|
|
|
|
|
x |
|
|
|
|
|
|
|
|
|
|
854 |
(RS)-3-Allyl-2-methyl-4-oxocyclopent-2-enyl-(1R,3R;1R,3S)-2,2-dimethyl-3-(2-methylprop-1-enyl)-cyclopropanecarboxylate (mixture of 4 isomers 1R trans, 1R: 1R trans, 1S: 1R cis, 1R: 1R cis, 1S 4:4:1:1) (d-Allethrin) |
DE |
Plant protection product |
231937-89-6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x |
|
|
|
|
855 |
(RS)-3-Allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)-cyclopropanecarboxylate (mixture of 2 isomers 1R trans: 1R/S only 1:3) (Esbiothrin) |
DE |
Plant protection product |
260359-57-7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x |
|
|
|
|
843 |
4-Bromo-2-(4-chlorophenyl)-1-ethoxymethyl-5-trifluoromethylpyrrole-3-carbonitrile (Chlorfenapyr) |
PT |
Plant protection product |
122453-73-0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x |
|
|
|
|
859 |
Polymer of N-Methylmethanamine (Einecs 204-697-4 with (chloromethyl)oxirane (Einecs 203-439-8)/Polymeric quaternary ammonium chloride (PQ Polymer) |
HU |
Polymer |
25988-97-0 |
|
x |
|
|
|
|
|
|
|
|
x |
|
|
|
|
|
|
|
|
868 |
Polyhexamethylene biguanide hydrochloride with a mean number-average molecular weight (Mn) of 1415 and a mean polydispersity (PDI) of 4,7 (PHMB(1415;4,7)) |
FR |
Polymer |
32289-58-0 and 1802181-67-4 |
|
|
x |
|
|
|
|
|
x |
|
x |
|
|
|
|
|
|
|
|
869 |
Poly(oxy-1,2-ethanediyl),.alpha.-[2-(didecylmethylammonio)ethyl]-.omega.-hydroxy-, propanoate (salt) (Bardap 26) |
IT |
Polymer |
94667-33-1 |
|
x |
|
x |
|
|
|
|
|
x |
|
|
|
|
|
|
|
|
|
872 |
N-Didecyl-N-dipolyethoxyammonium borate/Didecylpolyoxethylammonium borate (Polymeric betaine) |
EL |
Polymer |
214710-34-6 |
|
|
|
|
|
|
|
x |
|
|
|
|
|
|
|
|
|
|
|
1059 |
Capsicum oleoresin Extractives and their physically modified derivatives. It is a product which may contain resin acids and their esters, terpenes, and oxidation or polymerization products of these terpenes. (Capsicum frutescens, Solanaceae) |
BE |
Not available |
8023-77-6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x |
|
|
|
1060 |
Capsicum annuum, ext. Extractives and their physically modified derivatives such as tinctures, concretes, absolutes, essential oils, oleoresins, terpenes, terpene-free fractions, distillates, residues, etc., obtained from Capsicum annuum, Solanaceae. |
BE |
283-403-6 |
84625-29-6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x |
|
|
|
1061 |
Reaction mass of (6E)-N-(4-hydroxy-3-methoxy-2-methylphenyl)-8-methylnon-6-enamide and N-(4-hydroxy-3-methoxy-2-methylphenyl)-8-methylnonanamide |
BE |
Not available |
Not available |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x |
|
|
|
1062 |
D-Fructose |
AT |
200-333-3 |
57-48-7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x |
|
|
|
1063 |
Honey |
AT |
|
8028-66-8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x |
|
|
|
1064 |
Malt, ext. Extractives and their physically modified derivatives such as tinctures, concretes, absolutes, essential oils, oleoresins, terpenes, terpene-free fractions, distillates, residues, etc., obtained from Hordeum, Gramineae. |
AT |
232-310-9 |
8002-48-0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x |
|
|
|
1065 |
Vinegar (food grade containing a maximum of 10 % acetic acid) |
AT |
Not available |
8028-52-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x |
|
|
|
1066 |
Cheese |
AT |
Not available |
Not available |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x |
|
|
|
1067 |
Powdered egg |
NL |
Not available |
Not available |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x |
|
|
|
1068 |
Saccharomyces cerevisiae |
NL |
Not available |
68876-77-7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x |
|
|
|
1069 |
Concentrated apple juice |
NL |
Not available |
Not available |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x |
|
|
|
1070 |
Orange, sweet, ext. Extractives and their physically modified derivatives such as tinctures, concretes, absolutes, essential oils, oleoresins, terpenes, terpene-free fractions, distillates, residues, etc., obtained from Citrus sinensis, Rutaceae. |
CH |
232-433-8 |
8028-48-6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x |
|
|
|
1071 |
Garlic, ext. Extractives and their physically modified derivatives such as tinctures, concretes, absolutes, essential oils, oleoresins, terpenes, terpene-free fractions, distillates, residues, etc., obtained from Allium sativum, Liliaceae. |
AT |
232-371-1 |
8008-99-9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x’ |
|
|